all ( 12 results found)

Sort by:

Date Last Updated:

Medicine Status DHPC Document Name Additional Communications Company Zolgensma 2 × 1013 vector genomes/mL solution for infusion
No Recent Update

Zolgensma (onasemnogene abeparvovec): Important Safety Information

Novartis Ireland Limited
Quinsair 240 mg nebuliser solution
No Recent Update

Fluoroquinolones DHPC_HPRA_FINAL vs2 30-05-23

Chiesi Limited
Gavreto 100 mg hard capsules
No Recent Update

Gavreto DHPC dated 16 Jun 2023

Roche Registration GmbH
Dzuveo 30 micrograms sublingual tablet
No Recent Update

Dzuveo DHCP letter

Dzuveo cover letter

Aguettant Ltd
Epipen 300 micrograms solution for injection in pre-filled pen
No Recent Update

EpiPen® Healthcare Professional Letter

EpiPen® Healthcare Professional Letter

EpiPen® Healthcare Professional Letter

Mylan IRE Healthcare Ltd
Epipen Junior 150 micrograms solution for injection in pre-filled pen
No Recent Update

EpiPen® Healthcare Professional Letter

EpiPen® Healthcare Professional Letter

Mylan IRE Healthcare Ltd
Topamax 100mg film-coated tablets
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

Topiramate: New restrictions to prevent exposure during pregnancy

Janssen Sciences Ireland
Topamax 200mg film-coated tablets
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

Janssen Sciences Ireland
Topamax 25mg film-coated tablet
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

Janssen Sciences Ireland
Topamax 50mg film-coated tablets
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

Janssen Sciences Ireland
Topamax Sprinkle 25 mg hard capsules
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

Topiramate: New restrictions to prevent exposure during pregnancy

Janssen Sciences Ireland
Topamax Sprinkle 15 mg hard capsules
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

Janssen Sciences Ireland